On-Demand Sessions

Join GI physicians from the U.S. and around the world for the virtual ACG Annual Scientific Meeting. ACG 2020 will deliver the latest clinical information on timely topics in gastroenterology and hepatology.

NEW for ACG 2020! We have added an ACG All Access Pass, combine the three ACG Friday courses with the Postgraduate Course and the Annual Meeting plus the two bonus sessions (formerly the Learning Lunches and Breakfast Sessions) and save 20 percent! Register for any two courses and save up to 10 percent!

On-Demand Sessions
Symposium 1: Non-IBD Colitides
Moderator: Aline Charabaty, MD
  • Microscopic/Collagenous Colitis: Beyond Budesonide
    Anita Afzali, MD, MPH, FACG
    Explain the diagnosis and etiologies of colitis, with a focus on treatment of difficult-to-treat disease.
  • Poo-pourri: Immune, NSAIDs, and Beyond
    Aline Charabaty, MD
    Discuss the presentation and management of common non-IBD etiologies of colitis, including NSAID-induced, immune-mediated, and more.
  • Bugs, Vectors and Toxins: A Primer on Infectious Colitides
    Brooks D. Cash, MD, FACG
    Recognize infectious colitides commonly seen in GI practice.
Symposium 2: Common Scenarios in Crohn’s Disease: What Should I Do?
Moderator: David A. Schwartz, MD, FACG
  • Post-Operative Recurrence
    Miguel D. Regueiro, MD, FACG
    Describe monitoring and medical treatment of Crohn’s disease after surgical resection.
  • Management of Perianal Disease
    David A. Schwartz, MD, FACG
    Explain traditional and experimental treatments used in management of perianal Crohn’s disease.
  • Small Bowel Crohn’s
    Gil Y. Melmed, MD, MS, FACG
    Discuss the available tests for diagnosis and treatment of small bowel Crohn’s using CT, MR, capsule, and balloon enteroscopy.
Symposium 3: Refractory Conditions of the Esophagus: Diagnosis and Treatment
Moderator: John C. Fang, MD
  • Approach to Refractory Esophageal Strictures
    John C. Fang, MD
    Identify the different methods to successfully treat refractory esophageal strictures.
  • Identification and Management of Esophageal Manifestations of Dermatologic Conditions
    Magnus Halland, MD
    Recognize the clinical, endoscopic, and histopathologic presentations of dermatologic diseases affecting the esophagus.
  • Management of Treatment Failure in Achalasia
    Joel E. Richter, MD, MACG
    Explain management strategies for post myotomy reflux and chest pain in patients with achalasia
Symposium 4: Recent Developments in Barrett’s Esophagus
Moderator: Nicholas J. Shaheen, MD, MPH, MACG
  • New Tools for Diagnosis
    Gary W. Falk, MD, MS, FACG
    Describe the recent advances in diagnosis and surveillance of Barrett’s, including pre- and post-ablation which may allow for earlier, better detection of dysplasia and cancer.
  • Current Approach to Ablation
    Nicholas J. Shaheen, MD, MPH, MACG
    Discuss the outcomes of studies on RFA/cryoablation for Barrett’s esophagus - dysplastic and non-dysplastic - and the current controversies in treatment of BE.
  • Role of Chemoprevention
    Joel H. Rubenstein, MD, FACG
    Evaluate current chemoprevention options - as well as drugs in the clinical trial stage – aimed at preventing dysplasia and cancer in patients with BE.
Symposium 5: NASH
Moderator: Cynthia A. Moylan, MD
  • Natural History of NAFLD
    Cynthia A. Moylan, MD
    Discuss the epidemiology and epigenetics of NAFLD.
  • Diagnostic Approach to NAFLD
    Naim Alkhouri, MD
    Identify the diagnostic approaches to NAFLD.
  • Therapy for NAFLD
    Zobair M. Younossi MD, MPH, FACG
    Outline the dietary and medical therapies for NAFLD.
Symposium 6: Updates in Liver Transplantation and HCC for the Busy Gastroenterologist
Moderator: Philip K. Henderson, DO
  • Liver Transplantation
    Philip K. Henderson, DO
    Recognize patients in need of liver transplant evaluation.
  • Outpatient Management of OLT Patients
    Gina Choi, MD
    Understand the long-term follow-up for patients who have undergone liver transplantation to promote quality care.
  • Hepatocellular Carcinoma Primer
    Anjana A. Pillai, MD
    Identify patients with HCC and those who would benefit from medical therapy or liver transplantation.
Symposium 7: Nausea and Vomiting: Evolving Insights and Clinical Challengesy
Moderator: Braden Kuo, MD
  • Practical Insights From the Neurobiology of Nausea and Vomiting
    Braden Kuo, MD
    Describe how the neurobiology of nausea and vomiting influences treatment options.
  • Emerging Treatment: Pharmacologic and Non-Pharmacologic Options for Nausea and Vomiting
    Linda Anh B. Nguyen, MD
    Compare latest treatment strategies for nausea and vomiting.
  • Treatment of Gastroparesis: Beyond the Old Standbys
    Baharak Moshiree, MD, FACG
    Summarize recent pharmacologic and interventional advances in the management of gastroparesis.
Symposium 8: 50 Shades of Bloating: Multiple Perspectives on a Vexing Condition
Moderator: Kyle D. Staller, MD, MPH
  • It’s All Gas Production: Dietary and Microbial Factors
    Ali Rezaie, MD, MSc
    Recognize the role of gut microbiota and diet in the pathogenesis of bloating.
  • It’s All Hot Air: Bloating Is a Sensory Symptom
    Kyle D. Staller, MD, MPH
    Explain the role of the brain-gut axis in the generation of bloating symptoms.
  • Motility Matters Most!
    Gregory S. Sayuk, MD, MPH, FACG
    Appraise the evidence available regarding motility agents in bloating.
Symposium 9: Endoscopy in 2020 and Beyond: An Update
Moderator: Michael J. Levy, MD
  • Best Practice Paradigms for Performing a High Quality ERCP
    Vivek Kaul, MD, FACG
    Explain the evidence-based best practice principles for performing a high quality ERCP for optimal patient outcomes.
  • Endoscopic Ultrasound: Current Status and Future Direction
    Michael J. Levy, MD
    Illustrate current and future developments in EUS as they relate to a general GI practice and quality parameters.
  • Bariatric Endoscopy: Strides Made and the Road Ahead
    Violeta B. Popov, MD, PhD, FACG
    Discuss how the field of bariatric endoscopy has evolved and what the future holds, including challenges and opportunities.
Symposium 10: What’s New With Small Bowel Disorders?
Moderators: Peter H.R. Green, MD, FACG
  • Common Clinical Scenarios Surrounding Celiac Disease
    Peter H.R. Green, MD, FACG
    Differentiate celiac disease from mimicking conditions and define the approach to non-responders on a gluten-free diet.
  • Small Intestinal Bacterial Overgrowth: What’s New?
    Richard J. Saad, MD, FACG
    Discuss the ACG guidelines on diagnosis and treatment of SIBO.
  • Short Bowel Syndrome: An Update
    Carol E. Semrad, MD, FACG
    Identify current challenges in the care of patients with short bowel syndrome and describe treatment strategies.
Past Presidents’ Symposium
Moderators: Irving M. Pike, MD, FACG
  • New Developments in Hereditary Cancer Syndromes
    Carol A. Burke, MD, FACG
    Sapna Syngal, MD, MPH, FACG
  • Endoscopic Management of IBD
    Sunanda V. Kane, MD, MSPH, FACG
    Bo Shen, MD, FACG
  • New Treatments for IBS
    Eammon M. M. Quigley, MD, MACG
    Yuri A. Saito-Loftus, MD, MPH
Plenary Session 1
Plenary Session 2
Plenary Session 3
Plenary Session 4
Plenary Session 5
Plenary Session 6
Plenary Session 7
Plenary Session 8